1. Home
  2. SUPN vs CENX Comparison

SUPN vs CENX Comparison

Compare SUPN & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • CENX
  • Stock Information
  • Founded
  • SUPN 2005
  • CENX 1995
  • Country
  • SUPN United States
  • CENX United States
  • Employees
  • SUPN N/A
  • CENX N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • CENX Aluminum
  • Sector
  • SUPN Health Care
  • CENX Industrials
  • Exchange
  • SUPN Nasdaq
  • CENX Nasdaq
  • Market Cap
  • SUPN 1.8B
  • CENX 1.5B
  • IPO Year
  • SUPN 2012
  • CENX 1996
  • Fundamental
  • Price
  • SUPN $31.91
  • CENX $18.79
  • Analyst Decision
  • SUPN Hold
  • CENX Strong Buy
  • Analyst Count
  • SUPN 2
  • CENX 3
  • Target Price
  • SUPN $36.00
  • CENX $23.00
  • AVG Volume (30 Days)
  • SUPN 460.6K
  • CENX 1.8M
  • Earning Date
  • SUPN 05-06-2025
  • CENX 05-07-2025
  • Dividend Yield
  • SUPN N/A
  • CENX N/A
  • EPS Growth
  • SUPN N/A
  • CENX N/A
  • EPS
  • SUPN 1.11
  • CENX 1.22
  • Revenue
  • SUPN $667,997,000.00
  • CENX $2,364,700,000.00
  • Revenue This Year
  • SUPN N/A
  • CENX $6.79
  • Revenue Next Year
  • SUPN $8.74
  • CENX $3.58
  • P/E Ratio
  • SUPN $28.64
  • CENX $15.40
  • Revenue Growth
  • SUPN 11.82
  • CENX 11.41
  • 52 Week Low
  • SUPN $25.53
  • CENX $11.40
  • 52 Week High
  • SUPN $40.28
  • CENX $25.39
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 47.71
  • CENX 64.51
  • Support Level
  • SUPN $31.56
  • CENX $15.13
  • Resistance Level
  • SUPN $32.85
  • CENX $16.36
  • Average True Range (ATR)
  • SUPN 0.78
  • CENX 0.71
  • MACD
  • SUPN -0.08
  • CENX 0.16
  • Stochastic Oscillator
  • SUPN 24.38
  • CENX 69.06

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

Share on Social Networks: